UCLA Begins Recruitment For Phase 3 Of The Oxford University - AstraZeneca COVID-19 Vaccine Trial

The vaccine, developed by Oxford University and AstraZeneca, is called AZD1222and has successfully gone through earlier smaller phase 1 and 2 trials.